|
| 36862685 | Machine learning for the identification of respiratory viral attachment machinery from sequences data. | PLoS One | 2023 |
| 37112765 | Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2. | Vaccines (Basel) | 2023 |
| 36530725 | No magic bullet: Limiting in-school transmission in the face of variable SARS-CoV-2 viral loads. | Front Public Health | 2022 |
| 34799659 | Controlling long-term SARS-CoV-2 infections can slow viral evolution and reduce the risk of treatment failure. | Sci Rep | 2021 |
| 33909660 | Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein. | PLoS One | 2021 |
| 34818335 | Rapid relaxation of pandemic restrictions after vaccine rollout favors growth of SARS-CoV-2 variants: A model-based analysis. | PLoS One | 2021 |
| 29931092 | Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome. | Eur Heart J | 2018 |
| 28923873 | An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections. | Antimicrob Agents Chemother | 2017 |
| 25948407 | Genome-wide association study of perioperative myocardial infarction after coronary artery bypass surgery. | BMJ Open | 2015 |
| 26542501 | A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial infarction: Rationale and design of the PRESERVATION I trial. | Am Heart J | 2015 |
| 26176600 | Evaluating Free Energies of Binding and Conservation of Crystallographic Waters Using SZMAP. | J Chem Inf Model | 2015 |
| 24490951 | Fragment-based lead discovery and design. | J Chem Inf Model | 2014 |
| 24881672 | Ensemble-based docking using biased molecular dynamics. | J Chem Inf Model | 2014 |
| 22869295 | Virtual fragment screening: exploration of MM-PBSA re-scoring. | J Comput Aided Mol Des | 2012 |
| 23043329 | Discovery of selective and potent inhibitors of gram-positive bacterial thymidylate kinase (TMK). | J Med Chem | 2012 |
| 22908966 | In vivo validation of thymidylate kinase (TMK) with a rationally designed, selective antibacterial compound. | ACS Chem Biol | 2012 |
| 21315207 | A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trial. | Am Heart J | 2011 |
| 21982657 | A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction. | Am Heart J | 2011 |
| 20666458 | Identification and characterization of acidic mammalian chitinase inhibitors. | J Med Chem | 2010 |
| 19286091 | Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study. | Lancet | 2009 |
| 19565336 | Challenges of fragment screening. | J Comput Aided Mol Des | 2009 |
| 19495993 | Virtual fragment screening: an exploration of various docking and scoring protocols for fragments using Glide. | J Comput Aided Mol Des | 2009 |
| 19241384 | Triad of polar residues implicated in pH specificity of acidic mammalian chitinase. | Protein Sci | 2009 |
| 18411262 | Ganglioside inhibition of neurite outgrowth requires Nogo receptor function: identification of interaction sites and development of novel antagonists. | J Biol Chem | 2008 |
| 18783200 | Identification, characterization and initial hit-to-lead optimization of a series of 4-arylamino-3-pyridinecarbonitrile as protein kinase C theta (PKCtheta) inhibitors. | J Med Chem | 2008 |
| 18798205 | Structure-based optimization of protein tyrosine phosphatase-1 B inhibitors: capturing interactions with arginine 24. | ChemMedChem | 2008 |
| 18465849 | Investigation of MM-PBSA rescoring of docking poses. | J Chem Inf Model | 2008 |
| 18612831 | CONFIRM: connecting fragments found in receptor molecules. | J Comput Aided Mol Des | 2008 |
| 17064892 | Identification of potent and selective TACE inhibitors via the S1 pocket. | Bioorg Med Chem Lett | 2007 |
| 17956269 | Structure-based optimization of PKCtheta inhibitors. | Biochem Soc Trans | 2007 |
| 17606376 | Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket. | Bioorg Med Chem | 2007 |
| 17531482 | Design and synthesis of 3,3-piperidine hydroxamate analogs as selective TACE inhibitors. | Bioorg Med Chem Lett | 2007 |
| 17554852 | Lead optimization via high-throughput molecular docking. | Curr Opin Drug Discov Devel | 2007 |
| 17705360 | Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site. | J Med Chem | 2007 |
| 17657565 | Ligand design by a combinatorial approach based on modeling and experiment: application to HLA-DR4. | J Comput Aided Mol Des | 2007 |
| 17715908 | Inhibitors of tumor progression loci-2 (Tpl2) kinase and tumor necrosis factor alpha (TNF-alpha) production: selectivity and in vivo antiinflammatory activity of novel 8-substituted-4-anilino-6-aminoquinoline-3-carbonitriles. | J Med Chem | 2007 |
| 17336064 | Probing acid replacements of thiophene PTP1B inhibitors. | Bioorg Med Chem Lett | 2007 |
| 16303309 | Bicyclic and tricyclic thiophenes as protein tyrosine phosphatase 1B inhibitors. | Bioorg Med Chem | 2006 |
| 16806920 | Monocyclic thiophenes as protein tyrosine phosphatase 1B inhibitors: capturing interactions with Asp48. | Bioorg Med Chem Lett | 2006 |
| 16545564 | 1,2,4-Oxadiazolidin-3,5-diones and 1,3,5-triazin-2,4,6-triones as cytosolic phospholipase A2alpha inhibitors. | Bioorg Med Chem Lett | 2006 |
| 16335920 | Use of structure-based drug design approaches to obtain novel anthranilic acid acyl carrier protein synthase inhibitors. | J Med Chem | 2005 |
| 16215511 | A helpline for patients with chronic dermatological conditions. | Br J Nurs | 2005 |
| 16209958 | The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics. | Am Heart J | 2005 |
| 14684293 | Anthranilate 4H-oxazol-5-ones: novel small molecule antibacterial acyl carrier protein synthase (AcpS) inhibitors. | Bioorg Med Chem Lett | 2004 |
| 15566296 | Synthesis and structure-activity relationships of 4-alkynyloxy phenyl sulfanyl, sulfinyl, and sulfonyl alkyl hydroxamates as tumor necrosis factor-alpha converting enzyme and matrix metalloproteinase inhibitors. | J Med Chem | 2004 |
| 15464679 | Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy). | Am J Cardiol | 2004 |
| 15364937 | Catalytic domain crystal structure of protein kinase C-theta (PKCtheta). | J Biol Chem | 2004 |
| 12660987 | Pharmacophore-based molecular docking to account for ligand flexibility. | Proteins | 2003 |
| 12972102 | Reduction of myocardial ischemic injury following coronary intervention (the MC-1 to Eliminate Necrosis and Damage trial). | Am J Cardiol | 2003 |
| 14643356 | Structure-activity relationships of indole cytosolic phospholipase A(2)alpha inhibitors: substrate mimetics. | Bioorg Med Chem Lett | 2003 |